MedPath

HOSPIRA, INC

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

13

FDA:13

Drug Approvals

Ceftriaxone Sodium

Approval Date
Jan 10, 2024
FDA

Ceftriaxone Sodium

Approval Date
Jan 10, 2024
FDA

Ceftriaxone Sodium

Approval Date
Jan 10, 2024
FDA

Piperacillin and Tazobactam

Approval Date
Apr 30, 2023
FDA

Piperacillin and Tazobactam

Approval Date
Mar 31, 2023
FDA

Piperacillin and Tazobactam

Approval Date
Mar 29, 2023
FDA

Ceftriaxone Sodium

Approval Date
Mar 15, 2022
FDA

Ceftriaxone Sodium

Approval Date
Mar 15, 2022
FDA

Ceftriaxone Sodium

Approval Date
Mar 9, 2022
FDA

Ampicillin and Sulbactam

Approval Date
Oct 27, 2020
FDA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.